Related Experiment Video
Updated: May 3, 2026
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
20.5K
Noncardiovascular mortality in CKD: an epidemiological perspective
Dinanda J de Jager1, Marc G Vervloet2, Friedo W Dekker1
1Department of Clinical Epidemiology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Netherlands.
Nature Reviews. Nephrology
|February 5, 2014
Summary
Patients with chronic kidney disease (CKD) face higher mortality risks. This review examines both cardiovascular and noncardiovascular causes of death in CKD patients, highlighting shared risk factors and mechanisms.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Patients with chronic kidney disease (CKD) exhibit elevated all-cause mortality.
- Cardiovascular mortality is well-documented in end-stage renal disease (ESRD).
- Noncardiovascular mortality in CKD is increasingly recognized as a significant concern.
Purpose of the Study:
- To discuss cardiovascular and noncardiovascular mortality in CKD.
- To detail noncardiovascular causes of death in CKD patients.
- To explore shared risk factors and pathophysiological mechanisms.
Main Methods:
- Review of existing literature on mortality in CKD.
- Analysis of studies detailing noncardiovascular causes of death.
- Examination of risk factors associated with both cardiovascular and noncardiovascular mortality.
Main Results:
- Several factors, including fetuin-A, troponin T, C-reactive protein, vitamin D deficiency, and proteinuria, are linked to both cardiovascular and noncardiovascular mortality.
- Inflammatory reactions and the uraemic milieu are potential pathophysiological mechanisms.
- CKD is associated with increased risks for both cardiovascular and noncardiovascular death.
Conclusions:
- Future research must address both cardiovascular and noncardiovascular mortality in CKD.
- Investigating the interplay between causal pathways for cardiovascular and noncardiovascular mortality is crucial.
- A comprehensive approach is needed to reduce overall mortality in CKD patients.
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
01:25Chronic Kidney Disease I: Introduction
1.4K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
01:28Chronic Kidney Disease III: Interprofessional Care
679
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
01:18Chronic Kidney Disease IV: Nursing Management
682
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
682
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
337
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
337
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
559
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559